Cpwm, LLC Bristol Myers Squibb CO Transaction History

Cpwm, LLC

$1.06 Billion
Q3 2022

A detailed history of Cpwm, LLC transactions in Bristol Myers Squibb CO stock. As of the latest transaction made, Cpwm, LLC holds 27,610 shares of BMY stock, worth $1.62 Million. This represents 0.18% of its overall portfolio holdings.

Number of Shares

27,610

Previous 30,833 10.45%

Holding current value

$1.62 Million

Previous $2.37 Million 17.31%

% of portfolio

0.18%

Previous 0.21%

23 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2022 Nov 14, 2022	SELL	$0.13 - $76.84 $418 - $247,655	-3,223 Reduced 10.45%	27,610 $1.96 Million
Q2 2022 Aug 12, 2022	BUY	$72.62 - $79.98 $238,701 - $262,894	3,287 Added 11.93%	30,833 $2.37 Million
Q1 2022 May 13, 2022	BUY	$61.48 - $73.72 $435,893 - $522,674	7,090 Added 34.66%	27,546 $2.01 Million
Q3 2021 Nov 12, 2021	BUY	$59.17 - $69.31 $1,597 - $1,871	27 Added 0.13%	20,456 $1.21 Million
Q2 2021 Aug 13, 2021	SELL	$61.91 - $67.42 $17,953 - $19,551	-290 Reduced 1.4%	20,429 $1.37 Million
Q1 2021 May 14, 2021	BUY	$59.34 - $66.74 $16,733 - $18,820	282 Added 1.38%	20,719 $1.31 Million
Q4 2020 Feb 12, 2021	BUY	$57.74 - $65.43 $15,358 - $17,404	266 Added 1.32%	20,437 $1.27 Million
Q3 2020 Nov 13, 2020	SELL	$57.43 - $63.64 $689 - $763	-12 Reduced 0.06%	20,171 $1.22 Million
Q2 2020 Aug 13, 2020	SELL	$54.82 - $64.09 $27,848 - $32,557	-508 Reduced 2.46%	20,183 $1.19 Million
Q1 2020 May 11, 2020	SELL	$46.4 - $67.43 $116,928 - $169,923	-2,520 Reduced 10.86%	20,691 $1.15 Million
Q4 2019 Feb 12, 2020	BUY	$49.21 - $64.19 $787,507 - $1.03 Million	16,003 Added 222.02%	23,211 $1.49 Million
Q3 2019 Nov 13, 2019	BUY	$42.77 - $50.71 $24,763 - $29,361	579 Added 8.73%	7,208 $366,000
Q2 2019 Aug 02, 2019	SELL	$44.62 - $49.34 $13,073 - $14,456	-293 Reduced 4.23%	6,629 $301,000
Q1 2019 May 06, 2019	SELL	$45.12 - $53.8 $11,640 - $13,880	-258 Reduced 3.59%	6,922 $330,000
Q4 2018 Feb 08, 2019	SELL	$48.76 - $63.23 $13,652 - $17,704	-280 Reduced 3.75%	7,180 $373,000
Q3 2018 Nov 13, 2018	SELL	$55.19 - $62.25 $59,384 - $66,981	-1,076 Reduced 12.61%	7,460 $463,000
Q2 2018 Dec 21, 2018	SELL	$50.53 - $62.98 $411,415 - $512,783	-8,142 Reduced 48.82%	8,536 $472,000
Q2 2018 Aug 09, 2018	BUY	$50.53 - $62.98 $388,525 - $484,253	7,689 Added 85.54%	16,678 $923,000
Q1 2018 Dec 21, 2018	BUY	$59.92 - $68.98 $262,509 - $302,201	4,381 Added 95.07%	8,989 $569,000
Q1 2018 May 15, 2018	SELL	$59.92 - $68.98 $801,370 - $922,538	-13,374 Reduced 74.37%	4,608 $291,000
Q4 2017 Feb 02, 2018	SELL	$59.94 - $65.35 $98,721 - $107,631	-1,647 Reduced 8.39%	17,982 $1.1 Million
Q3 2017 Nov 14, 2017	SELL	$55.23 - $63.74 $189,438 - $218,628	-3,430 Reduced 14.87%	19,629 $1.25 Million
Q2 2017 Aug 14, 2017	BUY	N/A	23,059	23,059 $1.29 Million

Others Institutions Holding BMY

# of Institutions

2,536

Shares Held

1.47B

Call Options Held

31.6M

Put Options Held

35M

View Full List

About BRISTOL MYERS SQUIBB CO

Ticker BMY
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 2,126,160,000
Market Cap $125B
Description
Bristol-Myers Squibb Company discovers, develops, licenses, manufactures, and markets biopharmaceutical products worldwide. It offers products for hematology, oncology, cardiovascular, immunology, fibrotic, neuroscience, and covid-19 diseases. The company's products include Revlimid, an oral immunomodulatory drug for the treatment of multiple my...

More about BMY

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Cpwm, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Cpwm, LLC with notifications on news.

Account